March is for Myeloma Awareness 2025

 Allyson Spring and her parents Dr. Ken and Paula Moskowitz celebrate a successful fundraiser.

Post by: Allyson Spring. 

March 3, 2025 

March Is Multiple Myeloma Awareness Month ๐Ÿฉธ

March is Multiple Myeloma Awareness Month, dedicated to raising awareness about multiple myeloma, a type of blood cancer that affects plasma cells in the bone marrow. Over 35,000 people in the U.S. are diagnosed with myeloma each year, and it remains the second most common blood cancer.

Despite advancements in treatment, multiple myeloma is still considered incurable, though research continues to improve survival rates and quality of life. Raising awareness and funding research is critical to finding a cure.

Understanding Multiple Myeloma

• What is Multiple Myeloma?

Multiple myeloma occurs when abnormal plasma cells grow uncontrollably in the bone marrow, crowding out healthy blood cells. This can lead to bone damage, kidney failure, anemia, and a weakened immune system.

• Who is at Risk?

• Most commonly diagnosed in people over 65 years old

• More prevalent in African Americans

• Slightly more common in men than women

• Survival Rates Are Improving

Thanks to research and new treatments like CAR-T therapy, monoclonal antibodies, and proteasome inhibitors, the five-year survival rate for myeloma has improved significantly, now around 59%—but there’s still more work to do.

Advancements in Myeloma Research

๐Ÿ”ฌ Exciting breakthroughs include:

• CAR-T Cell Therapy – Personalized immunotherapy that targets and destroys myeloma cells.

• Bispecific Antibodies – New treatments that harness the immune system to attack cancer cells.

• Early Detection Research – Studies on how to catch myeloma in its earliest stages to improve treatment outcomes.

Organizations like The Leukemia & Lymphoma Society (LLS) and the International Myeloma Foundation (IMF) are funding groundbreaking research, helping patients live longer and healthier lives.

How You Can Help in March

1️⃣ Support Fundraising & Research

Every dollar makes a difference! Donate to organizations like:

➡️ Leukemia & Lymphoma Society (LLS)

➡️ International Myeloma Foundation (IMF)

2️⃣ Raise Awareness and Follow my Blog! 

https://allysonspringcom.wordpress.com

• Wear burgundy, the official color for Multiple Myeloma Awareness.

• Share your support on social media using #MarchForMyeloma #MultipleMyelomaAwareness #LightTheNight #KennyKrusaders

• Educate others about early symptoms like bone pain, fatigue, frequent infections, and kidney issues.

3️⃣ Honor Those Affected

Allyson Spring, Allyson, Spring, Courtesy Photo, 2025
My Dad Ken Moskowitz and I (Allyson Spring)

This March, I’m honoring my father, Dr. Ken Moskowitz, who fought multiple myeloma for eight years before passing in 2013. In his memory, I am fundraising for LLS’s Light The Night Team – Kenny’s Krusaders to help fund research, patient support, and a future cure.

Allyson Spring, Courtesy Photo, Allyson Spring.
Ken Moskowitz & Allyson Spring 

๐Ÿ”— Join us in the fight! Donate or sign up to support our cause: Light the Night – Kenny’s Krusaders

Donate: 

Allyson Spring 2025 Visionaries 

Together, We Can Make a Difference

By spreading awareness, funding research, and supporting patients, we can work toward better treatments, early detection, and ultimately, a cure for multiple myeloma.

Let’s make March a month of action. Donate, share, and advocate for myeloma research!

Allyson Spring, VA, 2025, Courtesy Photo, Allyson Spring.
Allyson Spring & Ken Moskowitz 

#MultipleMyelomaAwareness #AllysonSpring #MarchForMyeloma #BloodCancerAwareness #LightTheNight #KennyKrusaders #CancerResearch #LLS #IMF #HopeForACure #MyelomaWarriors

Allyson Spring Fundraising Blog

Comments

  1. Ken was a friend and mentor to me. Thank you Allyson for continuing to support LLS!

    ReplyDelete

Post a Comment

Popular posts from this blog

Fundraising & Perseverance: Why Resilience Drives Success

Join Allyson Spring in the Fight Against Blood Cancer – Visionaries of the Year 2025 Campaign TODAy